Skip to content
Home/Companies/Pharma/Genetic
GE

Genetic

Pharma·Italy·Active·1yr hold

Genetic is a pharma company, headquartered in Italy.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Genetic?

Genetic is currently owned by Renaissance Partners through Renaissance Partners Fund IV (2025 vintage), since 2025. Across its history, Genetic has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-21

Renaissance Partners
Most recent investor
Renaissance Partners
Renaissance Partners Fund IV · 2025 · Mid-Large Buyout
2 ownership periods · full history below

Key facts

HQItaly
SectorPharma
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Aurora Growth Capital and Renaissance Partners since 2025.
Co-invest · 2 holders · 2025 · present
Aurora Growth Capital
Aurora Growth CapitalActive
2025 · present · Aurora Growth Capital (SICAV-RAIF) · 2018 · Growth
MOIC
–
Renaissance Partners
Renaissance PartnersActive
2025 · present · Renaissance Partners Fund IV · 2025 · Mid-Large Buyout
MOIC
–

More from Renaissance Partners Fund IV

Other portfolio companies in the same fund.

Lodestar
Active
IT ServicesItaly· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
cormeo
Active
Bertelsmann InvestmentsGermany· 2025
Crossject
Active
VATEL CAPITALFrance· 2025
Data refreshed weekly · Sourced from public filings